PRA International Inc.

J. Matthew Bond joined PRA as vice president-finance and accounting in 2001, and was appointed senior vice president and chief financial officer of PRA in 2002. Before joining PRA, Mr. Bond worked as vice president for a division of Marriott International, Inc. since 1997. He also spent 11 years with a major public accounting firm. Mr. Bond is a Certified Public Accountant and holds a B.S. in business from Wake Forest University. He is a board member of Concept Interiors, Inc.

Bucky Walsh was named Executive Vice President, Corporate Development in 2006 after serving as Senior Vice President, Business Services since 2003. Over his 21 year career with PRA, Mr. Walsh has held a series of increasingly responsible technical, business development and managerial positions in both the United States and Europe.

David W. Dockhorn, Ph.D., was named Executive Vice President, Product Registration-The Americas in September 2007. He is charged with directing PRA's operations in the Americas and delivering overall client satisfaction. Dr. Dockhorn has held several leadership positions at PRA. Most recently he served as Executive Vice President, Clinical Operations, a position he held since 2003. Prior to that he was Senior Vice President, North American Clinical Operations for the company. Dr. Dockhorn joined PRA International in 1997 as Vice President of Operations and Regional Director of the Lenexa, Kansas operations. Under his leadership, the Lenexa office became PRA's fastest growing and most profitable trials management center. Before joining PRA, Dr. Dockhorn worked, along side his father Dr. Robert Dockhorn, for International Medical Technical Consultants, Inc. (IMTCI), a Clinical Research Organization acquired by PRA in 1997. There, he focused on data management and clinical trials, including Phases I IV. He held positions of increasing responsibility, from Study Coordinator to Vice President of Clinical Research. He also developed therapeutic expertise in the respiratory field. Dr. Dockhorn received his Ph.D. in neuroscience from Texas Tech University.

William (Bucky) Walsh, III, joined PRA in 1985, and was named senior vice president of business services in 2002. Mr. Walsh has been with PRA for more than 19 years, and has held numerous positions, including program analyst, director of systems and information technology, and vice president of systems management. While at PRA in 1991, Mr. Walsh earned an M.B.A. from James Madison University. In 1980, Mr. Walsh graduated with a B.A. from the University of Virginia.

Tami Klerr-Naivar was named Senior Vice President of Business Development in August, 2008. Ms. Klerr-Naivar joined PRA from InfaCare Pharmaceutical Corporation where she held the position of Vice President of Clinical Operations. Prior to that, Ms. Klerr-Naivar spent 13 years with Pharmaceutical Product Development, Inc. (PPD) in a variety of senior roles in business development, key account management and operations. Along with her extensive business development and operational skills, Ms. Klerr-Naivar brings a strong portfolio of therapeutic experience. Ms. Klerr-Naivar earned a BS from University of Pennsylvania.

Willem Jan Drijfhout, Ph.D., became Senior Vice President of Early Development Services in 2006, heading all early phase development and bioanalytical lab work for PRA International. Dr. Drijfhout was Chief Scientific Officer for Pharma Bio-Research prior to the company being acquired by PRA. He joined Pharma Bio-Research in 1996 and became a member of the Executive Board in 1999. A pharmacologist by training, with more than 15 years of experience in drug development and 12 years of experience in Phase I clinical trials, he has been involved in the study design and conduct of several hundred Phase I studies. Dr. Drijfhout holds a Ph.D. in Pharmacy.

Armin Kessler - Armin M. Kessler served as Chief Operating Officer of Hoffmann-La Roche in Basel Switzerland from 1990 to 1995. Prior to being appointed COO, he held several senior positions at Hoffmann-La Roche, including head of the pharmaceutical and diagnostic divisions of the organization. Earlier positions in his career included Director of Pharmaceutical Marketing Worldwide for Sandoz (now Novartis) and President of Sandoz KK in Tokyo. He currently serves on the board of The Medicines Company, Gen_Probe and Spectrum Pharmaceuticals (formerly Neotherapeutics) and has served on the boards of Hoffmann-La Roche, Syntex and Genentech. He received a degree in Physics and Chemistry from Pretoria University in South Africa, a degree in Chemical Engineering from the University of Cape Town, South Africa, a Juris Doctorate from Seton Hall University, New Jersey, and Dr. h.c. in Business Administration from the University of Pretoria.

Array

Mr. Conway has served as Chief Executive Officer and as a member of the board of directors since November 1999. Prior to joining Array, Mr. Conway was the Chief Operating Officer and Executive Vice President of Hill Top Research, from 1996 to 1999. From 1979 until 1996, Mr. Conway held various executive positions for Corning, Inc. including Corporate Vice President and General Manager of Corning Hazleton, a preclinical contract research organization. Mr. Conway currently serves on the board of directors of Biotechnology Industry Organization (BIO), DEMCO, Inc. and PRA International (PRAI) and is a member of the Strategic Advising Committee of Genstar Capital. Mr. Conway received a B.S. in accounting from Marquette University and an M.B.A from the University of Cincinnati.

Terry Bieker is Chief Executive Officer (CEO) and a member of the Board of Directors of PRA International. Mr. Bieker has led PRA since 2006, first as interim CEO then as permanent CEO in May 2007. He brings a wealth of global, strategic and operating experience to PRA, including executive positions in the fields of drug discovery, clinical diagnostics and medical devices. Prior to joining PRA, Mr. Bieker served as Director, President and Chief Executive Officer of BioSource International, Inc. from 2003 to 2005. His experience from 1999 to 2003 includes leadership roles as Director and Chief Executive Officer of several medical device corporations, including Axia Medical Solutions, and as Chief Operating Officer for SafeSkin, Inc. From 1989 to 1997, Mr. Bieker was Chairman, President and Chief Executive Officer of Sanofi Diagnostics Pasteur, Inc. Before that, he held various executive positions with Genetic Systems Corporation and American Hospital Supply Corporation. Mr. Bieker is a graduate of the University of Minnesota.